Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19,607,843
-
Total 13F shares
-
315,551
-
Share change
-
+71,708
-
Total reported value
-
$1,518,000
-
Price per share
-
$4.81
-
Number of holders
-
11
-
Value change
-
+$388,360
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q3 2020
As of 30 Sep 2020,
Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
315,551 shares.
The largest 10 holders included
Worth Venture Partners, LLC, Sterling Investment Advisors, Ltd., Independence Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, Paloma Partners Management Co, BROWN ADVISORY INC, MORGAN STANLEY, TWO SIGMA ADVISERS, LP, CANNELL PETER B & CO INC, and ADVISOR GROUP HOLDINGS, INC..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.